The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 15 April 2008, www.theannals.com, DOI 10.1345/aph.1K283.
 The Annals of Pharmacotherapy: Vol. 42, No. 5, pp. 704-707. DOI 10.1345/aph.1K283
© 2008 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.

Défis Relatifs à la Prescription Fondée sur les Preuves en Pratique

M Mamdani, A Ching, B Golden, M Melo, et U Menzefricke

Ann Pharmacother 2008;42:704-7.

Bien que le principe de prescription basée sur les preuves bénéficie d'un large consensus au sein de la communauté, il soulève également des défis majeurs et souvent justifiés. Une multitude de facteurs autres que les preuves existe et influence la prise de décision telle les préférences du patient, les circonstances sociales, l'interaction maladie-médicament ou médicament-médicament, l'expérience clinique, les demandes venant de conditions cliniques fréquentes, les activités promotionnelles et de mise en marché, et les politiques de soins de santé. Ce manuscrit révise les défis associés à la prescription basée sur les preuves et utilise comme exemple la substitution d'une statine pour une autre lors de l'introduction de nouvelles statines sur le marché.

Traduit par Marc M Perreault

www.theannals.com, DOI 10.1345/aph.1K283


This article has been cited by other articles:


Home page
 Fam PractHome page
P. B. Rahmner, L. L Gustafsson, J. Larsson, U. Rosenqvist, G. Tomson, and I. Holmstrom
Variations in understanding the drug-prescribing process: a qualitative study among Swedish GPs
Fam. Pract., April 1, 2009; 26(2): 121 - 127.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mamdani, M.
Right arrow Articles by Menzefricke, U.

homecopy help contact us subscription past issues search current issue
Copyright © 2008 by Harvey Whitney Books Company.